Atlas Venture
Massachusetts
Founded in 1980, Atlas Venture has organized seven international funds, and currently manages over $2.0 billion in committed capital, including a $600 million fund raised in April 2001. The Atlas Venture investment team is comprised of operating executives and career venture capitalists who have been involved with more than 350 companies in more than 16 different countries. Since 1995, 50 of Atlas' companies have been acquired and 40 are public. The firm prefers to invest in companies at their earliest stage and focuses on the life sciences and technology industries. Typical investments range from $500,000 to $5 million. Its most current fund, Atlas Venture VIII, is a 2009 vintage for which it held a single close at $283 million. The firm has divided into separate Life Sciences and Technology teams. The Life Sciences group will retain the Atlas name.
Founded:1980
Firm Location:Massachusetts • New York, New York • Boston, Massachusetts • Cambridge, Massachusetts • Boston / New England
Investor Firms That Co-Invest with Atlas Venture
SR OneInterWestCota CapitalGeneral AtlanticRA CapitalAME Cloud VenturesJohnson & Johnson InnovationRoche Venture FundF-Prime Capital PartnersKapor CapitalForesite CapitalHardware ClubWildcat VenturesLeaps by BayerCraft VenturesPillar VCNovartis Venture FundSV Health InvestorsFrazier Healthcare PartnersThe Column GroupPlayground GlobalARCH Venture PartnersVida VenturesThird Rock VenturesAutotech VenturesYsios CapitalHatteras Venture PartnersSV AngelGE VenturesPfizer Venture InvestmentsNew Enterprise Associates (NEA)DCVC (Data Collective)Aditum BioGreylockRedpoint VenturesKurma PartnersNextech InvestLongwood FundNest.Bio LabsBroadview VenturesvenBioForbionOmega FundsAndera PartnersAccess BiotechnologyBrandon Capital PartnersBorealis VenturesAdvent Life SciencesAcorn BioventuresM Ventures (Merck)INKEF CapitalHighbury GroupAdvanced Technology VenturesSoffinova PartnersPivotal bioVenture PartnersInnovation EndeavorsDigitalis VenturesMPM CapitalBreakthrough Energy VenturesBessemer Venture PartnersPolaris PartnersCanaan PartnersOrbiMedFelicis VenturesEQT Life SciencesGV (Google Ventures)Walden International
Atlas Venture Team
Investors in Cambridge (MA)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Boston / New England (Other Lists), Investors in Health & Hospital Services (Seed)
Investors in Cambridge (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Cambridge (MA)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Boston / New England (Other Lists), Investors in Health & Hospital Services (Seed)
Investors in Cambridge (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
Investors in Boston (MA), Investors in Cambridge (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
Investors in Cambridge (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)
Investors in Cambridge (MA)
Investors in Health & Hospital Services (Seed), Investors in Boston / New England (Other Lists), Investors in Health & Hospital Services (Seed)
Investors in Boston / New England
Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Boston (MA)
Investors in FinTech (Series B), Investors in FinTech (Seed), Investors in FinTech (Series A), Investors in FinTech (Series B), Investors in Boston / New England (Other Lists), Investors in FinTech (Series A), Investors in FinTech (Seed)
Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B)
Investors in Cambridge (MA)
Investors in Developer Tools (Seed), Investors in Developer Tools (Seed), Investors in Health & Hospital Services (Seed), Investors in Boston / New England (Other Lists), Investors in Health & Hospital Services (Seed)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)